XML 69 R59.htm IDEA: XBRL DOCUMENT v3.22.2
Equity - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended
May 18, 2022
Mar. 01, 2022
Jun. 30, 2022
May 20, 2022
Dec. 31, 2021
Jul. 16, 2021
Dec. 31, 2020
Stockholders Equity Details [Line Items]              
Common stock, shares authorized     730,000,000   730,000,000    
Common stock, par value (in Dollars per share)     $ 0.0001   $ 0.0001 $ 0.0001  
Common stock, voting Rights     common stock are entitled to one vote per share        
Preferred stock, shares authorized     10,000,000   10,000,000    
Preferred stock, shares issued     0   0    
Preferred stock, shares outstanding     0   0    
Class of warrant or right, outstanding     33,458,560        
Proceeds from PIPE financing     $ 30,000        
Fair value of the warrant liability     23,427   $ 25,962   $ 76,640
Proceeds from the exercise of warrants     $ 46,489        
Warrants              
Stockholders Equity Details [Line Items]              
Call price of public warrants     $ 0.01        
Minimum prior written notice period for redemption     30 days        
Description of call provision       • at any time while the Public Warrants are exercisable,   • upon not less than 30 days’ prior written notice of redemption to each Public Warrant holder,     • if, and only if, there is a current registration statement in effect with respect to the issuance of the common stock underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing        
May 2022 PIPE Warrants              
Stockholders Equity Details [Line Items]              
Class of warrant or right, outstanding     4,054,055        
Exercise per share price (in Dollars per share)     $ 8.25        
Warrants and rights outstanding, expire date     May 20, 2027        
Exercise price     $ 8.25        
May 2022 PIPE Warrants | Private Placement              
Stockholders Equity Details [Line Items]              
Proceeds from PIPE financing $ 30,000            
Net related cost 27,396            
Reduction to additional paid in capital 2,604            
Proceeds from issuance of private placement in additional paid in capital, net $ 7,651            
Exercise per share price (in Dollars per share) $ 8.25            
Warrants and rights outstanding, expire date May 20, 2027            
Term (years) 5 years            
Warrants and rights issued closing date May 20, 2022            
Fair value of the warrant liability       $ 19,745      
Exercise price $ 8.25            
Legacy Celularity              
Stockholders Equity Details [Line Items]              
Warrants outstanding to purchase shares of common stock   13,281,386          
Number of shares issued   13,281,386          
Issuance cost of equity   $ 15,985          
Minimum | Legacy Celularity              
Stockholders Equity Details [Line Items]              
Exercise per share price (in Dollars per share)   $ 3.50          
Exercise price   3.50          
Minimum | Legacy Celularity | Preferred Stock              
Stockholders Equity Details [Line Items]              
Percentage of shares required for voting     50.00%        
Maximum | Legacy Celularity              
Stockholders Equity Details [Line Items]              
Exercise per share price (in Dollars per share)   7.53          
Exercise price   $ 7.53          
Class A Common Stock              
Stockholders Equity Details [Line Items]              
Common stock, shares authorized     730,000,000        
Common stock, par value (in Dollars per share)     $ 0.0001     $ 0.0001  
Class of warrant or right, outstanding     33,458,560        
Class A Common Stock | May 2022 PIPE Warrants | Private Placement              
Stockholders Equity Details [Line Items]              
Class of warrant or right, outstanding 4,054,055            
Warrants outstanding to purchase shares of common stock 4,054,055            
Share price (in Dollars per share) $ 7.40            
Class A Common Stock | Legacy Celularity              
Stockholders Equity Details [Line Items]              
Proceeds from the exercise of warrants   $ 46,485